In vitro and in vivo effects of kinin B1 and B2 receptor agonists and antagonists in inbred control and cardiomyopathic hamsters

British Journal of Pharmacology

Volumn 129, Issue 8, 2000, Pages 1641-1648

  Halle S ^a   Gobeil Jr , F ^a   Ouellette, J ^b   Lambert, C ^b   Regoli, D ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Age; Cardiomyopathy; Hamster; Kinins; Tissues

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; CAPTOPRIL; ICATIBANT; RECEPTOR SUBTYPE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BINDING KINETICS; CARDIOMYOPATHY; CONTROLLED STUDY; HAMSTER; HYPOTENSION; IN VITRO STUDY; IN VIVO STUDY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; VASCULAR ENDOTHELIUM;

EID: 0034000127     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703269     Document Type: Article

References (31)

1. 2 receptor antagonist, FR 173657. Br. J. Pharmacol., 120, 617-624.
2. BASCANDS, J.L., PECHER, C., ROUAUD, S., EMOND, C., LEUNG TACK, J., BASTIE, M.J., BURCH, R., REGOLI, D. & GIROLAMI, J.P. (1993). Evidence for existence of two distinct bradykinin receptors on rat mesangial cells. Am. J. Physiol., 264, F548-F556.
3. 1 receptor blockade and ACE inhibition in (CHF 146) cardiomyopathic hamsters: Effects on cardiac hypertrophy and survival. Cardiovasc. Res., 43, 77-85.
4. CHEMLA, D., SCALBERT, E., DESCHÉ, P. & LECARPENTIER, Y. (1991). La cardiomyopathie du hamster Syrien. Arch. Mal. Coeur., 84, 85-87.
5. DRAPEAU, G. & REGOLI, D. (1988). Synthesis of bradykinin analogues. Methods Enzymol., 163, 263-272.
6. 2 receptor agonist (FR 190997) and antagonist (FR 173657). Immunopharmacology. 43, 179-185
7. 1 receptor-related peptides. Antagonists. Hypertension, 28, 833-839.
8. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, S.T., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, H.A. (1991). Hoe 140, a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
9. HUNTER, E.G., HUGUES, V. & WHITE, J. (1984). Cardiomyopathic hamsters, CHF 146 and CHF 147: a preliminary study. Can. J. Physiol. Pharmacol., 62, 1423-1428.
10. JENKINSON, D.H., BARNARD, E.A., HOYER, D., HUMPHREY, P.P.A., LEFF, P. & SHANKLEY, N.P. (1995). International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on Terms and Symbols in Quantitative Pharmacology. Pharmacol. Rev., 47, 255-266.
11. LAMBERT, C., MASSILLON, Y. & MELOCHE, S. (1995a). Reninangiotensin system and the congenital cardiomyopathic hamsters. In mecanisms of heart failure, ed. Signal P.K., Dixon I.M., Beamish, R.B. & Dhalla, N.S. pp. 203 214. Boston: Kluwer Academic Publishers.
12. 1 receptors in congenital cardiomyopathic hamsters. Circ Res., 77, 1001-1007.
13. LINZ, W., WIEMER, G., WIRTH, K. & SCHÖLKENS, B.A. (1997). The roles of kinins in the cardiac effects of ACE inhibitors and myocardial ischemia. In: Farmer, S. G., ed. The kinin system. Academic Press: London, pp115-323.
14. LOMMI, J., PULKKI, K., KOSKINEN, P., NAVERI, H., LEINONEN, H., HARKONEN, M. & KUPARI, M. (1997). Haemodynamic, neuroendocrine and metabolites correlates of circulating cytokine concentrations in congestive heart failure. Eur. Heart J., 18, 1620-1625.
15. 2 receptors in the renal tubular and hemodynamic responses to bradykinin. Am. J. Physiol., 262, R72-R76.
16. 1 receptors: a review. Immunopharmacology, 30, 1-26.
17. 1 receptors for kinins. Pharmacol. Rev., 50, 357-386.
18. 2+ signaling in single cultured vascular smooth muscle cells. Mol. Pharmacol., 50, 128-139.
19. 1 receptors. Br. J. Pharmacol., 117, 1619-1624.
20. 2 receptor mice. Naunyn-Schmiedeberg's Arch Pharmacol., 357, 191-196.
21. 2 receptors in the mouse. Can. J. Physiol. Pharmacol., 75, 558-562.
22. 2 receptors in the mouse. Can. J. Physiol. Pharmacol., 73, 1759-1764.
23. REGOLI, D., BARABÉ, J. & PARK, W.K. (1977). Receptors for bradykinin in rabbit aortae. Can. J. Physiol. Pharmacol., 55, 855-867.
24. REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
25. REGOLI, D., BOUDON, A. & FAUCHÈRE, J.L. (1994a). Receptors and antagonists for substance P and related peptides. Pharmacol. Rev., 46, 551-599.
26. 2 subtypes. Life Sci., 55, 735-749.
27. REGOLI, D., NSA ALLOGHO, S., RIZZI, A. & GOBEIL JR F. (1998). Bradykinin receptors and their antagonists. Eur. J. Pharmacol., 348, 1-10.
28. RHALEB, N.E., DION, S., BARABÉ, J., ROUISSI, N., JUKIE, D., DRAPEAU, G. & REGOLI, D. (1989). Receptors for Kinins in isolated arterial vessels of dogs. Eur. J. Pharmacol., 162, 419-427.
29. 2 receptor antagonist. An in vitro study. Hypertension, 29, 951-956.
30. 2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol. Pharmacol., 47, 525-534.
31. nded.), New York, U.S.A.: Springer Verlag.